Metraipolis › archive › dc_b4e37692d76b

Neoadjuvant Alectinib in a Patient With Anaplastic Lymphoma Kinase (ALK)-Mutant Stage III Lung Adenocarcinoma: A Case Report — Europe PMC PMID:41293380

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41293380
DOI
10.7759/cureus.95381
License (as archived)
solo-consultazione
Archived
2026-11-09T01:32:14.774Z
SHA-256 of the archived text
44598873091644c93a25bf58cf2a5d05b0dd8bab1999d6a4baa9d0e2ca26b47d
Stable URL of this page
https://metraipolis.com/documento/dc_b4e37692d76b

How to cite

Neoadjuvant Alectinib in a Patient With Anaplastic Lymphoma Kinase (ALK)-Mutant Stage III Lung Adenocarcinoma: A Case Report — Europe PMC PMID:41293380 — Europe PMC (en), https://europepmc.org/article/MED/41293380 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b4e37692d76b (Metraipolis archive dc_b4e37692d76b, sha256 44598873091644c93a25bf58cf2a5d05b0dd8bab1999d6a4baa9d0e2ca26b47d)
BibTeX
@misc{dcb4e37692d76b,
  title = {Neoadjuvant Alectinib in a Patient With Anaplastic Lymphoma Kinase (ALK)-Mutant Stage III Lung Adenocarcinoma: A Case Report — Europe PMC PMID:41293380},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41293380},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b4e37692d76b; sha256 44598873091644c93a25bf58cf2a5d05b0dd8bab1999d6a4baa9d0e2ca26b47d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41293380. Agents can read the archived copy with the MCP tool read_document.